{"id":"W2067533175","doi":"10.1016/s2213-8587(14)70174-3","title":"Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes","year":2014,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":362,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Manitoba","funders":"Novo Nordisk","keywords":"Insulin degludec; Liraglutide; Medicine; Metformin; Type 2 diabetes; Insulin; Pioglitazone; Clinical endpoint; Internal medicine; Diabetes mellitus; Urology; Endocrinology; Insulin glargine; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005373709,0.0003238427,0.001709548,0.0002730615,0.00006415637,0.00001782012,0.0002955484,0.00006726158,0.000006522226],"category_scores_gemma":[0.0004471123,0.0002125286,0.00003110527,0.0003943834,0.0003404604,0.0001286655,0.0002547137,0.0001664201,0.000002503054],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004344971,"about_ca_system_score_gemma":0.000045525,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007154445,"about_ca_topic_score_gemma":0.00003982677,"domain_scores_codex":[0.9974681,0.0003973164,0.0007940444,0.0004376452,0.0002857625,0.0006171747],"domain_scores_gemma":[0.9976164,0.0009194239,0.0005829977,0.0004958892,0.0002739571,0.0001113693],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6899688,0.01294223,0.2613479,0.0005736623,0.001801776,0.00001312906,0.00154894,0.0001392538,0.008409169,0.0006467275,0.0002877985,0.02232063],"study_design_scores_gemma":[0.6994163,0.01896627,0.2672073,0.0005034466,0.0005315949,7.496211e-7,0.00003650955,0.0008199645,0.01182112,0.00009239751,0.0003952408,0.0002091534],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936795,0.0005522362,0.00001139351,0.0006143927,0.00006448309,0.004441295,0.0001242452,0.00002599475,0.0004864282],"genre_scores_gemma":[0.9981672,0.0001882233,0.0008959618,0.0001628096,0.00003401402,0.0001577772,0.0003273981,0.00003345095,0.00003312737],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02211147,"threshold_uncertainty_score":0.8666664,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03207177693034416,"score_gpt":0.2833180045613597,"score_spread":0.2512462276310156,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}